AgaMatrix raises $56M to develop and sell its WaveForm CGM by Conor Hale Monday, July 8, 2019 AgaMatrix has secured about $56 million to support its continuous glucose monitor being developed under its WaveForm Technologies subsidiary.
Blue Earth Diagnostics sold to Bracco Imaging in $450M deal by Conor Hale Thursday, June 27, 2019 Molecular PET agent developer Blue Earth Diagnostics has been picked up by the Italian multinational Bracco.
Improving hemophilia gene therapies by tricking the immune system by Angus Liu Wednesday, May 22, 2019 An Italian team has developed a viral vector for hemophilia gene therapy and shown in monkeys that it may improve efficacy.
Italian cancer startup Philogen gets off impressive $70M round by Ben Adams Monday, May 13, 2019 Philogen has got off a healthy €62 million ($70 million) funding round and brought on new board members.
3 charities to fund £30M post-Brexit cancer research model by Conor Hale Wednesday, September 19, 2018 Three cancer charities will pour over $39 million into six U.K. and European research projects, to provide for a post-Brexit collaboration model.
Could an old RA drug make CAR-T treatments safer? by Arlene Weintraub Wednesday, June 6, 2018 Two new studies suggest that blocking the cytokine IL-1 with a rheumatoid arthritis drug could treat neurological side effects of CAR-T treatments.
Visual system changes in Parkinson’s hint at early detection by Nick Paul Taylor Monday, July 17, 2017 The finding suggests doctors could use biomarkers tied to the visual system to spot the disease early and monitor its advance.
A new weapon against rifampin-resistant bacteria by Amirah Al Idrus Thursday, June 15, 2017 A Rutgers University-led team has discovered a new antibiotic that could work against bacteria that have developed drug resistance.
Vesalius and AurorA-TT tee up €200M in Euro VCs funds by Nick Paul Taylor Thursday, May 18, 2017 The European biotech VC sector is set to get a €200 million injection of capital as Vesalius Biocapital and AurorA-TT introduce funds.
Spanish CRO Kymos acquires Italian firm Pharmaprogress by Angus Liu Monday, November 21, 2016 Spanish CRO Kymos has closed a deal to acquire Italy's Pharmaprogress as part of an ongoing expansion in the European market.